PulseAugur
EN
LIVE 18:32:13
ENTITY ozanimod

ozanimod

PulseAugur coverage of ozanimod — every cluster mentioning ozanimod across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
  1. 2026-11-11 product_launch An oral medication, ozanimod, showed improved response and remission rates for ulcerative colitis in a phase 2 trial. source
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. TOOL · CL_353480 ·

    Oral Ulcerative Colitis Drug Shows Promise in Phase 2 Trial

    A novel oral medication has shown promise in treating ulcerative colitis, demonstrating improved response and remission rates in a phase 2 trial. This development could offer a more convenient alternative to existing in…